Browsing Category

Type 2

Genetics was high on the agenda at this year’s EASD, with a move toward challenging the ‘one-size-fits-all’ approach of diagnosing and treating different types of diabetes. Using genetics to prevent Type 1 TrialNet screens relatives of people with Type 1 diabetes to work out their personal risk of developing the condition. They have now screened…

In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon updates on pharmacists, superbugs, epidemics, prescriptions, activity and psychological support. The pharmacist will see you now… NHS England is continuing to build on its programme of pharmacists working alongside GPs…

In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon updates on research. Treatment delays A new study has looked at ‘therapeutic inertia’ to try and estimate the size and cause of the problem in Type 2 diabetes (T2D). Therapeutic…

In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon updates on technologies, medicines and treatments. Big and bigger data Sugar.IQ is the first app to come out of a collaboration between Medtronic and IBM’s Watson supercomputer and it gives…